SCHEMBL9350679

SCHEMBL9350679

O=c1c2[nH]cnc2n(CC2CCCCC2)c(=O)n1CC1CC1

nearest known ligand 0.54

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
PDE4A P27815 10/20 0.54
PDE4B Q07343 10/20 0.54
PDE4C Q08493 10/20 0.54
PDE4D Q08499 10/20 0.54
PDE5A O76074 2/20 0.54
ADORA2B P29275 12/20 0.54
ADORA2A P29274 11/20 0.54
ADORA3 P0DMS8 1/20 0.45
ADORA1 P30542 1/20 0.45
PDE2A O00408 1/20 0.45
PDE1A P54750 1/20 0.45
PDE1B Q01064 1/20 0.45
PDE1C Q14123 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7025705 0.99 ADORA2B (0.55) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7021175 0.97 ADORA2B (0.56) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7018925 0.94 ADORA2B (0.56) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7029046 0.94 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL9354344 0.84 ADORA2B (0.47) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL19210142 0.82 PDE4A (0.68) PDE4APDE4BPDE4CPDE4DPDE5A
SCHEMBL7603838 0.79 PDE4A (0.55) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL10978398 0.78 PDE4A (0.59) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL25306092 0.78 PDE4A (0.66) PDE4APDE4BPDE4CPDE4DADORA2B
SCHEMBL15923707 0.77 PDE4A (0.60) PDE4APDE4BPDE4CPDE4DPDE5A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0369744-B1 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GMBH (DE) 1994-09-21 EP disclosed
US-5321029-A Vascular and skin disorders; bronchodilator BEECHAM-WUELFING GMBH & CO.K.G. (DE) 1994-06-14 US disclosed
EP-0369744-A2 Xanthine derivatives, process for their preparation and pharmaceutical compositions SMITHKLINE BEECHAM PHARMA GmbH (DE) 1990-05-23 EP disclosed